Showing results (1-10 of 587) with videos related to
Sort By:
Pageof 59
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2005
Site of relapse after chemotherapy alone for stage I and II Hodgkin's diseaseMehdi Shahidi, Nahid Kamangari, Sue Ashley, et al.Clinical Lymphoma & Myeloma|September 4, 2008
Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II studyVedang Murthy, Karen Thomas, Kerwyn Foo, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
The Role of Surveillance versus Adjuvant Treatment in Stage I Germ Cell Tumors: Outcomes and ChallengesAlan HorwichHematology (Amsterdam, Netherlands)|April 25, 2007
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)Bhawna Sirohi, David Cunningham, Andy Norman, et al.Current Opinion in Urology|August 13, 2002
Adjuvant chemotherapy for high-risk low-stage germ-cell tumoursAlan Horwich, Robert A HuddartHaematologica|February 14, 2007
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experienceHendrik-Tobias Arkenau, Geoff Chong, David Cunningham, et al.Lancet (London, England)|March 7, 2006
Testicular germ-cell cancerAlan Horwich, Janet Shipley, Robert HuddartAnnals of Hematology|October 26, 2013
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphomaEliza A Hawkes, Sarah Barton, David Cunningham, et al.Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Update on management of seminomaEmma J Alexander, Ingrid M White, Alan HorwichExpert Review of Anticancer Therapy|February 10, 2012
Minimizing toxicity in early-stage testicular cancer treatmentMausam Singhera, Kathryn Lees, Robert Huddart, et al.Pageof 59